| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 03/19/2008 | CN101143208A Sobering-up liver-protecting capsule and production method thereof |
| 03/19/2008 | CN101143201A Medicine for treating chronic obstructive lung disease and its preparation method |
| 03/19/2008 | CN101143199A Traditional Chinese medicine for treating chronic bronchitis |
| 03/19/2008 | CN101143196A Chinese proprietary medicine for salpingitis |
| 03/19/2008 | CN101143195A Traditional Chinese medicine for treating pulmonary tuberculosis and sequela |
| 03/19/2008 | CN101143191A Medicine capable of relieving side effects of mastocarinoma radiotherapy and chemotherapy |
| 03/19/2008 | CN101143190A Traditional Chinese medicine preparation for treating hemorrhoids toxic sore |
| 03/19/2008 | CN101143188A Traditional Chinese medicine for treating chronic asthma type brochitis |
| 03/19/2008 | CN101143187A Traditional Chinese medicine preparation capable of tranquilizing and heart and depression relieving |
| 03/19/2008 | CN101143184A Orally-administered traditional Chinese medicine for treating physique weakness type intestinal ascariasis |
| 03/19/2008 | CN101143182A Traditional Chinese medicine for treating alcoholic cirrhosis |
| 03/19/2008 | CN101143179A Traditional Chinese medicine for treating lumbato caused by lumbar muscle strain |
| 03/19/2008 | CN101143178A Traditional Chinese medicine for treating late esophagus cancer |
| 03/19/2008 | CN101143174A Traditional Chinese medicine formula for treating cervical erosion |
| 03/19/2008 | CN101143162A Medicinal liquor for treating mastoproliferation and its preparing process |
| 03/19/2008 | CN101143156A External-applied traditional Chinese medicine preparation for treating scald |
| 03/19/2008 | CN101143153A Lactobacillus signal molecule microecological preparation and preparation method thereof |
| 03/19/2008 | CN101143152A Dripping pill for treating digestive ulcer and medicine composition containing the same |
| 03/19/2008 | CN101142951A Anti-tumor active nanometer selenium-rich green tea preparation method and its product |
| 03/19/2008 | CN100375629C Pilose antler-glossy ganoderma capsule |
| 03/19/2008 | CN100375625C Quick thrombolysis for apoplexy |
| 03/19/2008 | CN100375612C Blood pressure lowering dripping pills with chryanthemum flower and pearl and its preparation process |
| 03/18/2008 | US7345089 Microbial method of making equol-containing composition and product made |
| 03/18/2008 | US7345026 A part of the coding sequence of the middle glycoprotein of the hepatitis B virus, which has a dna sequence coding for at least one tumor epitope of a tumor antigen inserted |
| 03/18/2008 | US7345025 Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells |
| 03/18/2008 | US7345023 Treatment of hyperproliferative conditions of body surfaces |
| 03/18/2008 | US7344881 Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby |
| 03/18/2008 | US7344872 involves engineering a recombinant shuttle vector comprising a nucleic acid cassette encoding prokaryotic green fluorescent protein (GFP) operably linked to regulatory sequences which permit its expression in a host cell |
| 03/18/2008 | US7344715 Method for treating multiple myeloma |
| 03/18/2008 | US7344714 Generation preferential antibody; construct peptide library, immunize cells, isolating and purify antisera from cells |
| 03/18/2008 | US7344712 Urinary tract tissue graft compositions and methods for producing same |
| 03/18/2008 | US7344711 Administering an adenovirus defective in its VAI and VAII virus-associated RNAs |
| 03/18/2008 | US7344710 Aministering synergistic mixture of Clostridium spores and anticancer agents |
| 03/18/2008 | CA2448908C Adenovirus protein ix, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization |
| 03/18/2008 | CA2315395C Compositions and methods for treatment of alopecia |
| 03/18/2008 | CA2191213C Lactobacillus strains of human origin, their compositions and uses thereof |
| 03/18/2008 | CA2181073C Tissue-specific enhancer active in prostate |
| 03/18/2008 | CA2166102C Redirection of cellular immunity by receptor chimeras |
| 03/13/2008 | WO2008030265A2 Combination pressure therapy |
| 03/13/2008 | WO2008029869A1 Agent for prevention or treatment of blood glucose level elevation |
| 03/13/2008 | WO2008029836A1 Study, determination or evaluation method |
| 03/13/2008 | WO2008029505A1 Agent for accelerating the increase in and/or preventing the decrease in blood adiponectin level, and visceral fat accumulation inhibitor |
| 03/13/2008 | WO2008028300A1 Oral polymeric membrane feruloyl esterase producing bacteria formulation |
| 03/13/2008 | WO2008013664A3 Methods of producing pancreatic hormones |
| 03/13/2008 | WO2008011884A8 Novel immunomodulator |
| 03/13/2008 | WO2008007383A8 Dried electrified hydrocolloid gels having unique structure and porosity |
| 03/13/2008 | WO2007128896A3 Protease inhibitor compound, notably papain, cathepsin k and cathepsin b, and a procedure for the purification of protease inhibitor molecules |
| 03/13/2008 | WO2007125566A3 Use of probiotics in the prevention and treatment of allergic conjunctivitis |
| 03/13/2008 | WO2007099401A3 Oncolytic attenuated reoviruses for treatment of proliferative disorders |
| 03/13/2008 | US20080064101 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
| 03/13/2008 | US20080064099 Propagating progenitor cell line from cell isolated from inner cell mass tissues; in vitro fertilization |
| 03/13/2008 | US20080064081 Reducing antigenicity of viral protein via amino acid sequence variation; enhancing vector transferability during gene therapy |
| 03/13/2008 | US20080063732 Tetanus toxin, conotoxin, curare, botulinum toxin, aluminum chloride, glycopyrrolate, robinol; treat facial rhytides, hyperhidrosis, muscle, sweat gland hyperactivity condition; collagen, hydrogel, dextran, hyaluronic acid, epinephrine diffusion-limiting agent, anti-metabolic agent |
| 03/13/2008 | US20080063715 Extracellular matrix to treat malignancy in mammals |
| 03/13/2008 | US20080063696 Use of penetration enhancers and barrier disruption methods to enhance the immune response of antigen and adjuvant |
| 03/13/2008 | US20080063684 Prosthetics; mixture of bone particles and polymer; room temperature vulcanization |
| 03/13/2008 | US20080063680 behaves like collagen in vivo yet is highly manipulative and elicits less to no negative immune response; submucosa tissue; implanting; a sterile pouch containing a sheet of submucosa tissue from a urinary tract of a pig |
| 03/13/2008 | US20080063677 Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations |
| 03/13/2008 | US20080063671 Hemostatic bone graft |
| 03/13/2008 | US20080063666 New lactic bacteria useful as probiotics |
| 03/13/2008 | US20080063662 Vaccine |
| 03/13/2008 | US20080063661 treating a wart with a fusion protein comprising (1) a heat shock protein and (2) a human papilloma virus (HPV) protein; Mycobacterium bovis heat shock protein; HPV is an E7 protein; cervical dysplasia, anal cancer, anal dysplasia |
| 03/13/2008 | US20080063656 Adenoviral Vector Compositions |
| 03/13/2008 | US20080063652 co-culture of hematopoietic progenitor cells and lymphoreticular stromal cells in a porous solid scaffold, resulting in unexpectedly high numbers of regulatory T cells |
| 03/13/2008 | US20080063643 HLA-binding motif in its sequence; recognized by an HLA-A2- or HLA-A24-restricted cytotoxic T cell; nucleotide; antibody; vector; diagnosid and prognosis of hepatitis C virus infection |
| 03/13/2008 | US20080063631 prophylaxis of vascular system disorders in mammals by administering apoptotic cells and/or bodies derived from leukocytes or lymphocytes |
| 03/13/2008 | US20080063630 polynucleotides that code for polypeptides having activity for targeting heterogeneous polypeptides to the surfaces of cytoplasmic membranes, useful for analysis of proteind, delivery of cells expressing the polypeptide to a target site in vivo, preparation of an antibodies and vaccines, and gene therapy |
| 03/13/2008 | US20080063629 culturing progenitor or stem cells with stromal cells in cytokines; genetic engineering |
| 03/13/2008 | US20080063628 increasing gene expression of genetic transcriptional regulators, using chromatin-remodeling agent comprising histone deacetylase inhibitors; cells used in the therapeutic treatment of diabetes |
| 03/13/2008 | US20080063627 collagenous tissue scaffolds bonded to biocompatibilzers via activated photoreactive groups; tissue engineering; reducing transplant rejection |
| 03/13/2008 | US20080063622 Composition and Method for Delivery of BMP-2 Amplifier/Co-Activator for Enhancement of Osteogenesis |
| 03/13/2008 | US20080063600 use of deactivated lymphocytes, antibodies, drug mixtures and adjuvants, for the treatment or prevention of Cruetzfield-Jacobs disease in humans or animals; immunology; bioassays |
| 03/13/2008 | CA2662710A1 Oral polymeric membrane feruloyl esterase producing bacteria formulation |
| 03/13/2008 | CA2662682A1 Agent for prevention or treatment of blood glucose level elevation |
| 03/12/2008 | EP1897553A1 Inhibitor of stem cell proliferation and uses thereof |
| 03/12/2008 | EP1897548A1 T cell regulation |
| 03/12/2008 | EP1897441A1 TGF-alpha polypeptides, functional fragments and methods of use therefor |
| 03/12/2008 | EP1896507A2 Anti-cd71 monoclonal antibodies and uses thereof for treating malignant tumour cells |
| 03/12/2008 | EP1567551A4 Colostrinin and peptides thereof as modulators of intracellular signaling molecules and inhibitors of apoptosis |
| 03/12/2008 | EP1537872A4 Immunostimulator having antineoplastic action and method for producing said immunostimulator |
| 03/12/2008 | EP1506317B1 Marker molecules associated with lung tumors |
| 03/12/2008 | EP1434590B1 Method for inhibiting the formation of seromas using factor xiii |
| 03/12/2008 | EP1408999B1 Compositions addressing inflammation and/or degenerative disorders |
| 03/12/2008 | EP0973538B1 Modified proteins which bind extracellular matrix components |
| 03/12/2008 | EP0614374B2 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 03/12/2008 | CN201033171Y Medicine label for treating arthralgia |
| 03/12/2008 | CN101142143A Process and kit for formation of active hydrogen water, gypsum feeder for the formation, active hydrogen forming materials and process for the production of the materials |
| 03/12/2008 | CN101139572A Ophiopogon root external sperm nutrient solution and preparation method and application thereof |
| 03/12/2008 | CN101139557A Lactobacillus casei and its application for improvement of blood lipid metabolism and immunological regulation |
| 03/12/2008 | CN101139380A Method for producing cholic acid by using bovine and sheep bile |
| 03/12/2008 | CN101138630A Fibrin glue composition for repairing nerve damage and methods thereof |
| 03/12/2008 | CN101138623A Medicament for preventing and treating deficiency of the kidney essence |
| 03/12/2008 | CN101138620A Chinese medicine for treating itching throat and dry cough |
| 03/12/2008 | CN101138619A Chinese medicine for treating endless cough |
| 03/12/2008 | CN101138616A Prescription for treating tummy bug |
| 03/12/2008 | CN101138615A Chinese medicine for treating intractable aypnia |
| 03/12/2008 | CN101138613A Chinese traditional medicine for treating acute bronchitis of children |
| 03/12/2008 | CN101138611A Compound radiating empyrosis aerosol |
| 03/12/2008 | CN101138610A Chinese medicinal herb prescription for treating dental disease and preparation method thereof |
| 03/12/2008 | CN101138607A Sea snake bining sugar-coating tablets and preparation method thereof |